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FOREWORD 
The hscussion on which this definitive document is 
based was drafted by the Working Party on Antibiotic 
Susceptibility Testing of the European Society of 
Clinical Microbiology and Infectious Diseases, the 
members of which were: I. Phillips (Chairman); 
J. Acar; T. Bergan; J. Degener; E Baquero; A. Forsgren; 
G-C. Schito and B. Wiedemann. 
The Working Party has now been subsumed in 
the European Committee on Antibiotic Susceptibility 
Testing (EUCAST) by whose authority th s  definitive 
document is published. 
The purpose of this document is to promote the 
uniform application of terminology to methods used 
for the determination of the susceptibility of bacteria 
to antimicrobial agents, and to facilitate communi- 
cation between the laboratory and the clinician, and 
between laboratories, nationally and internationally. 
Definition of t e r m  does not imply approval of any 
associated method or technique. 
1 ANTIBIOTIC 
An antibiotic is a substance of biological, semi- 
synthetic or synthetic origin (the last strictly on anti- 
bacterial chemotherapeutic agent), that shows selective 
activity against bacteria, and is thus of potential use in 
the treatment of infection. 
Disinfectants, antiseptics and preservatives are not 
included. 
2 TEST SUBSTANCES 
These are representatives among a group of antibiotics, 
that are specially suitable for in vitra investigations, and 
which represent, optimally, the spectrum of activity of 
the group, and allow a minimum number of substances 
to be tested. 
Ideally, in almost all cases, the antibiotic to be 
used clinically should be tested. This is possible 
only if the clinicians served by the laboratory have 
a common policy of restricted use, but results for 
other antibiotics may be useful in identification of 
resistance mechanisms (interpretive reading) and in 
identifting epidemiological trends. 
3 PATHIOGEN CHARACTERISTICS (Figure 1) 
3.1 Susceptible (S) (also sensitive) 
The term is used in two senses, one microbiological 
and tht. other clinical. We have been unable to agree 
terminology to resolve the resulting confusion. In each 
case the definition is based on an analysis of the 
distribution of the results of measurements of one or 
other of the parameters used to define susceptibility 
such as MIC (see Antibacterial Action). 
3.1.1 Microbiological Susceptibility: 
Susceptible (sensitive) bacteria are those that belong 
to the most susceptible sub-population and lack mech- 
anisms of resistance. 
3.1.2 Clinical Susceptibility: 
Susceptible (sensitive) bacteria are those, defined on 
the basis of in vitro parameters, which ideally have 
been shLown to respond to a standardized therapeutic 
regimen when causing infection. Some authorities 
divide fully susceptible bacteria (microbiologically 
susceptible) from borderline susceptible bacteria 
which, although they have a low-level resistance 
mechanism, usually respond to standard therapeutic 
regimens. The many other factors that affect response 
to therapy often make it difficult to determine the 
clinical effect of chemotherapy alone. 
In the absence of reliable clinical information, 
the definition is based on a consensus interpre- 
tation of the antibiotic’s in vitro properties and 
pharmacokinetics, and particularly on concentra- 
tions of antibiotic attainable at the site of infection 
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Figure 1 Hypothetical distribution of MICs among strains 
of bacteria isolated from infected patients, classified as 
Clinically Susceptible (fully or borderline), Intermediate or 
Resistant, and microbiologically Susceptible or Low-level, 
Moderately or High-level Resistant. 
(or often, as a practical approximation, in the 
blood). 
Bacteria with low-level microbiological resist- 
ance mechanisms may be clinically susceptible, 
though sometimes referred to as borderline suscep- 
tible. 
3.2 Resistant 
The term is used in two senses, one microbiological 
and the other clinical. 
3.2.1 Microbiological resistance 
Microbiologically resistant organisms are those that 
possess any resistance mechanism. The term may be 
qualified, as in “moderately or highly resistant” or 
“low-level, or high-level resistance”. 
3.2.2 Clinical resistance 
Clinical resistance occurs when infection is highly 
unlikely to respond even to maximum doses of a given 
antibiotic. 
The many other factors that affect response to 
therapy often make it difficult to determine the clinical 
effect of chemotherapy alone, even when pathogens are 
resistant in vitro. 
3.3 Intermediate 
A bacterium is classified as of intermediate suscepti- 
bility if it belongs to the group of strains that lies 
between the clinically susceptible and the clinically 
resistant. Infections caused by such strains have variable 
(or indeterminate) responses to chemotherapy, but may 
be eliminated if the antibiotic is concentrated at  the site 
of the infection or dosage is increased. 
3.4 Cross-Resistance 
This is complete or partial insusceptibility to a group 
of antibiotics. 
In its strict sense, cross resistance applies to anti- 
biotics of the same chemical class (e.g. p-lactams, 
aminoglycosides, or macrolides). However, resistance 
mechanisms such as those resulting from imperme- 
ability or efflux, may affect more than one chemical 
class: this is sometimes referred to as associated 
resistance. 
3.5 Susceptibility/resistance profile and antibiogram de- 
scribe the pattern of susceptibility to a series of 
antibiotics. 
A bacterium resistant to penicillin, strepto- 
mycin and tetracycline but susceptible to erythro- 
mycin may be described as having the resistance 
profile PST. Alternatively such an organism may 
be described by the antibiogram RRRS for the 
predefined sequence of antibiotics. 
4 SPECTRUM 
The term spectrum characterizes the range of activity 
of an antibiotic against various bacterial species, or 
groups of species (e.g. Gram-positive, Gram-negative, 
aerobic, facultatively anaerobic, obligate anaerobes). 
Acquired resistance may alter, from time to 
time and place to place, the pattern of susceptibility 
that originally defined the spectrum. 
5 BREAKPOINTS 
These are specific values of parameters such as MICs, 
or inhibition zone diameters (which can be correlated 
with MICs by suitable statistical methods) on the basis 
of which bacteria can be assigned to the clinical 
categories “susceptible (sensitive)”, “intermediate” and 
“resistant”. 
It is important to take particular note of the 
symbols used to define breakpoints: < means “less 
than”, while * means “equal to or less than”, and > 
means “greater than” while 2 means “equal to or 
greater than”. 
6 ANTIBACTERIAL ACTION 
6.1 The minimum inhibitory concentration (MlC) 
i s  the lowest concentration expressed in mg/L (numeri- 
cally equal to pg/ml, but we do not recommend the 
use ofsuch units) that, under defined in vitro conditions, 
E U C A S T  De f in i t i ve  Document  293 
prevents the growth of bacteria within a defined period 
of time. 
6.2 The minimum bactericidal concentration 
(MBC) is the lowest concentration of an antibiotic, 
expressed in mg/L, that under defined in vitro conditions 
reduces by 99.9% (3 logarithms), the number of organ- 
isms in a medium containing a defined inoculum of 
bacteria, within a defined period of time. 
The reduction is usually expressed as the pro- 
portion of the inoculum (number of living cfu intro- 
duced) that is rendered incapable of reproduction on 
subculture within that period. 
The effects can be presented as a time/kill curve in 
which an inoculum is incubated with the antibiotic 
and samples are tested for numbers of surviving cfb at  
defined time intervals. 
There are other definitions of MBC, and it is 
thus important to indicate which definition is being 
used. 
6.3 The optimum bactericidal concentration 
(OBC) or most bactericidal concentration is the 
concentration of antibiotic that results in the maximum 
proportionate kill within a given time. 
6.4 The minimum serum inhibitory concentra- 
tion (titre) is the reciprocal of the highest dilution 
(titre) of a serum sample from a patient or volunteer 
(dosed with an antibiotic), that prevents an increase 
in the number of organisms capable of reproduction 
within a defined period of time. It is usually expressed 
as the titre that prevents an increase in turbidity of a 
liquid culture on incubation. 
6.5 The minimum serum bactericidal concen- 
tration (titre) is the reciprocal of the highest dilution 
(titre) of a serum sample from a patient or volunteer, 
that is able to reduce the number of organisms capable 
of reproduction as colony-forming units (cfb), usually 
by 99.9%) (3 logarithms), within a defined period of 
time. 
6.6 The minimum antibacterial concentration 
(MAC) is the concentration of an antibiotic, below the 
MIC as defined above, that can exert specified bio- 
logical effects on bacteria. 
Such effects may include partial inhibition of 
growth below the MIC, changes in bacterial morph- 
ology, changes in adhesion to surfaces, acceleration of 
phagocytosis, increase or decrease of antimicrobial 
activity in combination with other antibiotics, pro- 
longation of generation times or changes in toxin 
production. 
6.7 Tolcrance 
Tolerance occurs when, under defined conditions, a 
test substance that is usually bactericidal for the bacteria 
tested shows a diminished or absent bactericidal effect 
without loss of inhibitory action (no change occurs in 
the MIC). The difference between MIC and MBC is 
usually quantified (eg 16-32 fold). Tolerance renders a 
normally bactericidal agent bacteriostatic. 
6.8 Persistence 
Persistence occurs when individual cells (persisters) 
survive the effects of an antibiotic, despite its concen- 
tration being above the MBC of the population as a 
whole. 
O n  retesting, persisters demonstrate the same 
susceptibdity as the original population as a whole and 
no  larger proportion of cells persists. 
6.9 A paradoxical effect (Eagle phenomenon) 
occurs when, in tests to determine the MBC of an 
antibiotic, organisms survive in significantly larger 
numbers on subculture from media containing anti- 
biotic concentrations above, but not immediately above, 
the MBC. 
6.10 A postantibiotic effect (PAE) is the delay of 
growth of bacteria (compared with that of a suitable 
control population containing the same number of 
bacteria) after a limited period of exposure to an 
antibiotic, after which the effect of the antibiotic 
is removed (e.g. by 2100-fold ddution or by filtration 
and washing). The term may also be applied to 
morphological or biochemical changes 
6.11 The postantibiotic effect index (PAE index) 
is the time needed for the cell count ( c fu /d )  of a 
population of microorganisms exposed to the MIC or 
more of an antibiotic over a defined period, to increase 
by a factor of ten (1 log) after removal or dilution of 
the antibiotic, in comparison with an untreated (but 
suitably cliluted) control culture. 
7 PROPERTIES OF ANTIBIOTICS 
7.1 Potency is the amount of antibacterially active 
agent in a test substance, determined by means of a 
bioassay, usually expressed in micrograms per milligram 
(pg/mg) of test substance 
7.2 The concentration is the amount of an antimicro- 
bial ageni: in a defined volume of liquid, preferably 
expressed as mg/L (rather than p g / d  or m c g / d )  or 
in a defined mass of a solid, usually expressed as pg/g 
or mg/kg. 
2 9 4  EUCAST D e f i n i t i v e  D o c u m e n t  
8 EFFECT OF COMBINATIONS OF ANTIBIOTICS 
(Table 1) 
The effects described occur in vitro: their clinical 
significance is unclear. 
8.3 Synergism 
Synergistic action of a combination of antibiotics or 
antibiotics and inactive substances, is present if the 
effect of the combination exceeds the adltive effects 
of the individual components. 
8.4 Antagonism 
Antagonism is present if a reduced effect of a combina- 
tion of antibiotics is observed in comparison with the 
Table 1 Correlation FIC and FBC and the effect of the 
combination of antibacterial agents 
Note: This docs not take account of the error introduced by the 
use of doubling dilutions. 
8.1 indifference 
An indifferent effect of a combination of antibiotics 
or antibiotics and inactive substances, is one that is 
equal to the effects of the individual substances. 
If one substance is more active than the other, 
indifference IS difficult to differentiate from an additive 
effect, especially when doubling dilutions of antibiotic 
are used. 
8.2 Additive Effects 
The additive effect of a combination of antibiotics is 
one in which the sum of the effects of the indwidual 
substances corresponds to the effect of the combina- 
tion. 
8.5 An isobologram is the figurative representation 
of the interaction of two antibiotics (Figure 2). 
8.6 Fractional inhibitory concentration (FIC), fractional 
bactericidal concentration (FBC), FIC index and average 
F IC index 
The fractional inhibitory concentration and the 
fractional bactericidal concentration are mathe- 
matical expressions of the effect of the combination of 
antibacterial agents (see 8.1 to 8.4) 
For two antibiotics A and B acting alone and in 
combination: 
The CFIC (FIC index) may be calculated according to 
log cnnc the following equation. 
Antibiotic A Antibiotic A 
CFIC = FIG(,\, + F I C ( I ~  
mp/L \ \ ~:I.. 1 indices. Che kerboard The sun1 titration of a number assays result of FIC in a indices number divided of FIC
\ , by the number ofindices is desicpated as average CFIC. 
\ \ The synergism/antagonisni criteria given in Table 1 
\ 
\ \ 
\ '\ apply. 
\ \ The FBC may b e  calculated in the same way 
by replacing the MIC values with the MBC values. 
The evaluation of the FIC and FBC is summarized in 
Table 1. 
0 Antibiotic B 0 Anh lohcB 
mg/L m p n  
a) synerg? b) antagonism 
8.7 Time-kill curves (vide infra Fig. 3) may also be 
L l y C I l d  
*-. linc teparating well\ ~ i t h  growth (to the left) from t l l o ~ e  with 
no growth (to thc right). 
- _ ~ _  Iinc of additive etkct. 
used to present data On interactions. 
9 STOCK SOLUTION 
Figure 2 Interpretation of an isolobolograni for two 
antibiotics A and B in a chcckerboard titration. 
A stock solution ofan antibiotic is the starting solution 
used for further dilution. 
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10 REFERENCE STRAINS 
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Reference strains are catalogued, characterised bacteria 
with stable, defined antibiotic susceptibility phenotypes. 
Reference strains are kept as stock cultures from 
which are derived working cultures. They are obtain- 
able fiom culture collections and used for quality control. 
11 SUSCEPTIBILITY (SENSITIVITY) TESTING METHODS 
11.1 Broth dilution 
Broth dilution is a technique in which containers are 
fdled with identical volumes of inoculated broth and 
identical volumes of an antibiotic solution, but incre- 
mentally (usually geometrically) increasing concen- 
trations of the antibiotic, and a defined inoculum. The 
aim of this method is the determination of the lowest 
concentration that inhibits bacterial growth - the 
minimum inhibitory concentration (MIC) or 
other parameters (see 11.3, 11.4). The broth dilution 
niethod may be performed by macrodilution or micro- 
dilution. 
11.1.1 Macrodilution denotes the performance of the 
broth dilution method in tubes containing a minimum 
volume of 2nd. 
11.1.2 Microdilution denotes the performance of the 
broth dilution method in microtitration plates with a 
capacity of 1500 pl per well. 
11.2 Agar dilution 
Agar dilution involves the incorporation of an 
antimicrobial agent in solid or semi-solid agar media 
in a geometrical progression of concentrations and 
the application of a defined bacterial inoculum to 
the surface. Its purpose is the determination of the 
lowest concentration that inhibits bacterial growth - 
minimum inhibitory concentration (MIC). (See 
also 12, 13, 14, 15). 
11.3 MBC determination. Containers are fded  with 
identical volumes of inoculated broth and identical 
volumes of an antibiotic, but incrementally (geo- 
metrically) increasing concentrations of the antibiotic, 
and a defined bacterial inoculum. Its purpose is the 
determination of the lowest concentration that reduces 
the number of viable bacteria present by more than 
99.9% afier a defined exposure time and subculture to 
antibiotic-free medium - the minimum bactericidal 
concentration (MBC). 
11.4 Killing kinetics. Time-kiU curves are figurative 
representations (Figure 3)  of bacterial concentrations 
time 
Figure 3 Hypothetical time-kill curves for two antibiotics 
A and B acting on a bacterial culture alone and in 
combination demonstrating synergism (the difference in 
Alog cfu/h for the combination being 3 2 fold that of the 
most active component). 
(cfu/ml) in subcultures taken serially from cultures, 
usually in liquid media, containing antibiotic(s). Killing 
kinetics, including the speed of kill (Alog cfu/h), can 
be deriked from them. 
11.5 Agar diffusion. Diffusion of the antibiotic from 
discs, tablets or strips, in solid inoculated culture media 
gives rise to inhibition zones whose diameters correlate 
with the minimum inhibitory concentrations (MICs) 
for the bacteria. 
12 MEDIUM 
The medium is a culture medium, which may be 
solidified with agar, which is used for the agar or broth 
dilution methods and the agar d i a s ion  test. 
13 INOCULUM 
The inoculum size is the number of bacteria in a 
suspension, calculated with respect to the final volume. 
It is expressed as colony-forming units per millilitre 
(cfu/ml). 
It may be defined less accurately in terms of the 
turbidity or optical density of the suspension. 
14 INHIHITION ZONE 
The inhibition zone is the area free of growth in a 
bacterial lawn, which results from the inhibitory effect 
of antibiotic that has diffused into the medium &om its 
applied source. 
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14.1 Inhibition zone diameter is measured in mdli- 
metres. 
14.2 Inhibition zone “radius” is the distance in mni 
from the edge of an antibiotic disc to the edge of the 
zone of inhibition of growth (i.e. is the radius of the 
zone of inhibition minus the radius of the disc). 
15 VEHICLES 
Vehicles serve as carriers for the antimicrobial agent for 
the determination of the susceptibility of a bacterial 
strain to be tested to the respective antimicrobial agents 
by means of the diffusion or dilution tests. Vehicles may 
be paper discs, strips, or tablets loaded with defined 
amounts of antibiotics and labelled accordingly. In the 
past, other vehicles such as wells or cylinders were used. 
15.1 A batch or lot comprises all vehicles consisting of 
the same material and produced from the same starting 
solution of an antimicrobial agent in an uninterrupted 
process. 
is the range of antibiotic load permitted to the manu- 
facturer around the stated amount in a vehicle (usually 
90-120%): this has no relationship with tolerance as 
defined in 6.7 above. 
15.3 Standardised abbreviations of antibiotic names, 
as used on susceptibhty testing discs, have not yet been 
agreed by EUCAST. 
15.4 Expiry date. An expiry date is given for each lot 
of loaded vehicles. I t  indicates that up to the specified 
date no fall in activity to 190% of the declared activity 
occurs under defined storage conditions. The expiry 
date is determined following stability testing. 
REVISIONS 
Revisions of this document will be considered by the 
Ternunology Sub-committee of EUCAST in January 
1999 Proposals for changes should be sent to EUCAST 
via Cornelia Hasselmann (Tel: +49 89 8971 2003, Fax 
+49 89 8971 2004) 
152 The disc content of antibiotic is defined in pg 
or units, and never as a concentration. The tolerance 
